Form D · Biotechnology

Evecxia, Inc.

Research Triangle Park, NC · CIK 0001736859

Offering snapshot reported Sep 29, 2025 · SEC filing

Reported sold
$4.61M
Offering amount: $8M
Investors reported
97
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 15, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 29, 2025Initial$4,613,213No comparison97SEC filing
Sep 6, 2023Initial$2,438,082No comparison76SEC filing
Aug 20, 2021Initial$8,620,691No comparisonNot reportedSEC filing
Sep 11, 2020Amendment$7,414,155$5,438,063vs Sep 17, 201991SEC filing
Sep 17, 2019Initial$1,976,092No comparison14SEC filing
Apr 13, 2018Initial$50,000No comparison2SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$329K
Finders' fees
$0
Form D file number
021-559098

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Collage Venture Partners, LLC316063Stonehaven LLC · CRD 118913

Source: Form D, filed Sep 29, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Thomas Aasen Director
Marc Caron Director, Executive
Elliot Ehrich Director
Jacob Jacobsen Director, Executive
Roger Jeffs Director
John Kaiser Director
Allan Shaw Director
Craig Robert Sincock Director
David Zaccardelli Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2 Davis Drive
Research Triangle Park, NC, 27709